TSE:4507Pharmaceuticals
Shionogi (TSE:4507) Q3 Net Margin Strength Challenges Cautious Earnings Growth Narratives
Shionogi (TSE:4507) has put up a solid set of Q3 2026 numbers, with revenue of ¥147.7b and basic EPS of ¥87.76 helping cap a trailing twelve month profile that shows revenue of ¥465.4b and basic EPS of ¥228.94. The company has seen quarterly revenue move from ¥99.8b in Q1 2026 to ¥113.2b in Q2 and then ¥147.7b in Q3, while basic EPS stepped from ¥46.26 to ¥51.92 and then ¥87.76 over the same stretch, giving investors a clear earnings season where higher sales have flowed through to healthy...